| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2010 | Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer | Liu P.-L.; Tsai J.-R.; Chiu C.-C.; Hwang J.-J.; Chou S.-H.; Wang C.-K.; Wu S.-J.; YUH-LIEN CHEN ; Chen W.-C.; Chen Y.-H.; Chong I.-W. | Molecular Carcinogenesis | 35 | 34 | |
| 2017 | Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - A Retrospective, Five-Year Multicenter Study | Huang H.-L.; Cheng M.-H.; Lu P.-L.; CHIN-CHUNG SHU ; JANN-YUAN WANG ; JANN-TAY WANG ; Chong I.-W.; LI-NA LEE | Scientific Reports | 47 | 48 | |
| 2021 | Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes | Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; CHONG-JEN YU ; HAO-CHIEN WANG ; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG ; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group | Scientific Reports | 10 | 9 | |
| 2021 | First-line anaplastic lymphoma kinase (Alk) inhibitors for alk-positive lung cancer in asian populations: Systematic review and network meta-analysis | Wu K.-L.; Chen H.-L.; Tsai Y.-M.; Lee T.-H.; Chang H.-M.; Tsai Y.-C.; Chuang C.-H.; Chang Y.-C.; YU-KANG TU ; Yang C.-J.; Hung J.-Y.; Chong I.-W. | Journal of Clinical Medicine | 5 | 5 | |
| 2010 | High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness | Liu P.-L.; Tsai J.-R.; Hwang J.-J.; Chou S.-H.; Cheng Y.-J.; Lin F.-Y.; YUH-LIEN CHEN ; Hung C.-Y.; Chen W.-C.; Chen Y.-H.; Chong I.-W. | American Journal of Respiratory Cell and Molecular Biology | 83 | 80 | |
| 2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; CHIH-HSIN YANG ; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO ; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | 6 | 2 | |
| 2019 | Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease | Liu C.-J.; Huang H.-L.; Cheng M.-H.; Lu P.-L.; CHIN-CHUNG SHU ; JANN-YUAN WANG ; Chong I.-W. | Respiratory Medicine | 10 | 9 | |
| 2018 | Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: A retrospective, longitudinal, multicentre study | Huang H.-L.; Cheng M.-H.; Lu P.-L.; Liu C.-J.; Chong I.-W.; JANN-YUAN WANG | Scientific Reports | 5 | 2 | |
| 2020 | Predictors of radiographic progression for NTM–pulmonary disease diagnosed by bronchoscopy | Huang H.-L.; MENG-RUI LEE ; Liu C.-J.; Cheng M.-H.; Lu P.-L.; JANN-YUAN WANG ; Chong I.-W. | Respiratory Medicine | 3 | 4 | |
| 2010 | Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-κB pathway and subsequently downregulating expression of matrix metalloproteinases | Liu P.-L.; Tsai J.-R.; Charles A.L.; Hwang J.-J.; Chou S.-H.; Ping Y.-H.; Lin F.-Y.; YUH-LIEN CHEN ; Hung C.-Y.; Chen W.-C.; Chen Y.-H.; Chong I.-W. | Molecular Nutrition and Food Research | 98 | 88 | |
| 2019 | Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists | Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; HAO-CHIEN WANG ; Chen L.; CHONG-JEN YU ; CHONG-JEN YU ; HAO-CHIEN WANG ; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG ; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Aging | 6 | 6 | |
| 2022 | Salvage therapy for relapsed malignant pleural mesothelioma: A systematic review and network meta-analysis | Tsai Y.-C.; Chen H.-L.; Lee T.-H.; Chang H.-M.; Wu K.-L.; Chuang C.-H.; Chang Y.-C.; YU-KANG TU ; Hung J.-Y.; Yang C.-J.; Chong I.-W. | Cancers | 2 | 1 | |
| 2010 | Second-hand smoke and chronic bronchitis in Taiwanese women: A health-care based study | Wu C.-F.; Feng N.-H.; Chong I.-W.; KUEN-YUH WU ; Lee C.-H.; Hwang J.-J.; Huang C.-T.; Lee C.-Y.; Chou S.-T.; Christiani D.C.; Wu M.-T. | BMC Public Health | 22 | 18 | |
| 2019 | Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients | Huang H.-L.; Liu C.-J.; MENG-RUI LEE ; Cheng M.-H.; Lu P.-L.; JANN-YUAN WANG ; Chong I.-W. | PLoS ONE | 3 | 2 | |
| 2021 | Systematic review and network meta-analysis of anaplastic lymphoma kinase (Alk) inhibitors for treatment-na?ve alk-positive lung cancer | Chuang C.-H.; Chen H.-L.; Chang H.-M.; Tsai Y.-C.; Wu K.-L.; Chen I.-H.; Chen K.-C.; Lee J.-Y.; Chang Y.-C.; Chen C.-L.; YU-KANG TU ; Hung J.-Y.; Yang C.-J.; Chong I.-W. | Cancers | 24 | 23 | |
| 2020 | Systematic review and network meta-analysis of immune checkpoint inhibitors in combination with chemotherapy as a first-line therapy for extensive-stage small cell carcinoma | Chen H.-L.; YU-KANG TU ; Chang H.-M.; Lee T.-H.; Wu K.-L.; Tsai Y.-C.; Lee M.-H.; Yang C.-J.; Hung J.-Y.; Chong I.-W. | Cancers | 15 | 13 |
